CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
2022 · Molecular Neurodegeneration · 96 citations
https://doi.org/10.1186/s13024-022-00545-9
P
Peter Bor‐Chian Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
1.2K
Citations
14
h-index
17
i10-index
Peter Bor‐Chian Lin is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Alzheimer's disease research and treatments & Neuroinflammation and Neurodegeneration Mechanisms & Tryptophan and brain disorders. The author has an h-index of 14, co-authored 56 publications.
ORCID: 0000-0002-8954-9045Papers by this author
worksGenetic variants of phospholipase C-γ2 alter the phenotype and function of microglia and confer differential risk for Alzheimer’s disease
2023 · Immunity · 64 citations
https://doi.org/10.1016/j.immuni.2023.08.008
Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer’s progression
2024 · Cell Reports · 20 citations
https://doi.org/10.1016/j.celrep.2024.114488
Assessment of neurovascular uncoupling: <i>APOE</i> status is a key driver of early metabolic and vascular dysfunction
2024 · Alzheimer s & Dementia · 12 citations
https://doi.org/10.1002/alz.13842
Regeneration leads to global tissue rejuvenation in aging sexual planarians
2025 · Nature Aging · 10 citations
https://doi.org/10.1038/s43587-025-00847-9
Additional file 1 of PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19200183
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat